Page last updated: 2024-08-16

ono 1078 and ezetimibe

ono 1078 has been researched along with ezetimibe in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Alméciga-Diaz, CJ; Garzón, R; Gorshkov, K; Guzman, E; Hidalgo, OA; Li, R; Olarte-Avellaneda, S; Pimentel-Vera, LN; Puentes-Tellez, MA; Rodríguez-López, A; Rojas-Rodriguez, AF; Zheng, W	1

Other Studies

2 other study(ies) available for ono 1078 and ezetimibe

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA. Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13 Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins	2019

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.

Journal of medicinal chemistry, 2019, 07-11, Volume: 62, Issue:13

Topics: Catalytic Domain; Chondroitinsulfatases; Chromones; Enzyme Inhibitors; Ezetimibe; Fibroblasts; HEK293 Cells; Humans; Lysosomes; Microtubule-Associated Proteins; Molecular Docking Simulation; Molecular Dynamics Simulation; Mucopolysaccharidosis IV; Pichia; Protein Binding; Protein Stability; Rare Diseases; Recombinant Proteins; RNA-Binding Proteins

2019